Weiner David B.'s Form 4 filing
Inovio Pharmaceuticals, Inc. (INO) · filed Mar 9, 2022
- Accession no.
- 0001055726-22-000014
- Filed
- Mar 9, 2022
- Trade date
- Mar 8-9, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $13.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weiner David B.CIK 0001669080 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 | Common Stock | MOption exerciseAcquired | +11,666 | –F1 | – | 880,124 | Direct | |
| Mar 9, 2022 | Common Stock | SSaleDisposed | −4,083 | $3.33 | −$13,596.39 | 876,041 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 | Common Stock | MOption exerciseDisposed | −11,666 | $0.00F1 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.